NYSE: KMBKimberly Clark Corp Stock
$136.43-1.35 (-0.98%)
Updated Apr 25, 2024
KMB Price
$136.43
Fair Value Price
N/A
Market Cap
$45.94B
52 Week Low
$116.32
52 Week High
$147.09
P/E
24.94x
P/B
44x
P/S
2.14x
PEG
0.93x
Dividend Yield
3.49%
Revenue
$20.39B
Earnings
$1.85B
Gross Margin
35.4%
Operating Margin
12.73%
Profit Margin
9.1%
Debt to Equity
15.24
Operating Cash Flow
$3B
Beta
0.46
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
KMB Overview
Kimberly-Clark Corporation manufactures personal care and consumer tissue products in the U.S. and internationally. Personal care offerings include disposable diapers, baby wipes, feminine and incontinence care products, and related products. Its brands names are Huggies, Pull-Ups, Little Swimmers, GoodNites, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and others. Tissue products offered include facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve brand names. Kimberly-Clark was founded in 1872 and is headquartered in Dallas, TX.
Zen Score
–
Industry Average (36)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how KMB scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
KMB ($136.43) is trading above its intrinsic value of $81.25, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
KMB is good value based on its earnings relative to its share price (24.94x), compared to the US market average (40.97x)
P/E vs Market Valuation
KMB is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more KMB due diligence checks available for Premium users.
Be the first to know about important KMB news, forecast changes, insider trades & much more!
KMB News
Valuation
KMB price to earnings (PE)
For valuing profitable companies with steady earnings
Company
24.94x
Industry
35.36x
Market
40.97x
KMB is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
KMB is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
KMB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
44x
Industry
7.38x
KMB is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
KMB price to earnings growth (PEG)
For valuing profitable companies with growth potential
KMB is good value based... subscribe to Premium to read more.
PEG Value Valuation
KMB's financial health
Profit margin
Revenue
$5.1B
Net Income
$647.0M
Profit Margin
12.6%
KMB's Earnings (EBIT) of $2.60B... subscribe to Premium to read more.
Interest Coverage Financials
KMB's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$17.1B
Liabilities
$15.9B
Debt to equity
15.24
KMB's short-term liabilities ($6.88B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
KMB's long-term liabilities ($9.03B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
KMB's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
KMB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$438.0M
Investing
-$181.0M
Financing
-$485.0M
KMB's operating cash flow ($3.37B)... subscribe to Premium to read more.
Debt Coverage Financials
KMB vs Household & Personal Product Stocks
Kimberly Clark Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.